Detalhe da pesquisa
1.
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Lancet Reg Health Am
; 21: 100497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192953
2.
Safety and effectiveness of CIMAvax-EGF administered in community polyclinics.
Front Oncol
; 13: 1287902, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304035
3.
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
EClinicalMedicine
; 46: 101383, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35434578